Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Innovation Pharmaceuticals Inc (IPIX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0021 0.0000    0.00%
03/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 21,062
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0019 - 0.0021
Innovation Pharma 0.0021 0.0000 0.00%

Innovation Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Innovation Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

4

Equity Type

ORD

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Contact Information

Address 301 Edgewater Place Suite 100
Wakefield, 01880
United States
Phone 978 921 4125
Fax -

Top Executives

Name Age Since Title
Paul Ginsburg - 2011 Scientific Advisor of Intellectual Property
Leo Ehrlich 63 2007 Chairman, CEO, CFO, Principal Accounting Officer & Secretary
Stephen T. Sonis - 2016 Scientific Advisor of Oral Mucositis & Member of the Advisory Board
Francis A. Farraye - - Scientific Advisor of Gastroenterology & Member of the Advisory Board
William F. DeGrado - 2020 Scientific Advisor of Drug Discovery & Clinical Development
Gustavo H. Goldman - 2023 Scientific Advisor of Mycology & Fungal Diseases and Member of the Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IPIX Comments

Write your thoughts about Innovation Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
michel galvez guerrero
michel galvez guerrero Mar 16, 2021 7:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waiting for preliminary results of Ph2 in humans, If they are positive we will go to dollars Some links: https: //clinicaltrials.gov/ct2/show/NCT04784897? Term = brilacidin & draw = 2 & rank = 2s respecto al Innovation Pharmaceuticals Inc http://www.ipharminc.com/press-release/2021/1/14/innovation-pharmaceuticals-brilacidin-for-the-treatment-of-covid-19-receives-fda-fast-track-designation http://www.ipharminc.com/press-release/2021/3/2/innovation-pharmaceuticals-announces-publication-of-peer-reviewed-scientific-article-in-the-journal-viruses-on-the-anti-sars-cov-2-properties-of-brilacidin
Lars Holland
Lars Holland Nov 03, 2020 11:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Innovation Pharmaceuticals Receives Pre-IND Response from FDA: Stock Jumps https://pennystocks.news/innovation-pharmaceuticals-receives-pre-ind-response-from-fda-stock-jumps-ipix/
wbag Lovers
wbag Lovers Jul 22, 2020 4:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tommorow will be green
Stephen McGuire
Stephen McGuire Jul 20, 2020 5:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Brilacidin to the Moon...on it's way to Mars....
nasser ayish
nasser ayish Jul 20, 2020 5:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the target?
wbag Lovers
wbag Lovers Jul 20, 2020 12:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yup! To the moon
Connor Murphy
Connor Murphy Jun 17, 2020 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Brilacidin to the moon!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email